[Federal Register: July 21, 2009 (Volume 74, Number 138)]
[Notices]
[Page 35863-35864]
[DOCID:fr21jy09-54]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings  1

July 9, 2009.
    Take notice that the Commission received the following electric
corporate filings:

    Docket Numbers: EC07-30-002; EC09-65-001.
    Applicants: KGen Hinds LLC, KGen Hot Spring LLC, KGen Murray I and
II LLC, KGEN Sandersville LLC.
    Description: Supplemental Filing of KGen Hinds LLC, KGen Hot Spring
LLC, KGen Murray I and II LLC and KGen Sandersville LLC.
    Filed Date: 07/08/2009.
    Accession Number: 20090708-5099.
    Comment Date: 5 p.m. Eastern Time on Wednesday, July 29, 2009.

    Take notice that the Commission received the following electric
rate filings:

    Docket Numbers: ER01-1099-013; ER02-1406-014; ER99-2928-010.
    Applicants: Cleco Power LLC; Acadia Power Partners, LLC; Cleco
Evangeline LLC.
    Description: Cleco Companies submits an updated market power
analysis for the Cleco Companies, supporting

continued allowance of market-based rates in geographic markets etc.
    Filed Date: 06/30/2009.
    Accession Number: 20090630-0055.
    Comment Date: 5 p.m. Eastern Time on Tuesday, July 21, 2009.

    Docket Numbers: ER01-1403-010; ER06-1443-006; ER04-366-008; ER01-
2968-011; ER01-845-009; ER05-1122-007; ER08-107-004.
    Applicants: FirstEnergy Operating Companies, Pennsylvania Power
Company, Jersey Central Power & Light Co., FirstEnergy Solutions Corp.,
FirstEnergy Generation Corporation; FirstEnergy Nuclear Generation
Corporation, FirstEnergy Generation Mansfield Unit 1.
    Description: Supplemental Information of FirstEnergy Generation
Corp., et. al. regarding post-Study Year Energy Purchases from Wind-
Powered Generators.
    Filed Date: 06/30/2009.
    Accession Number: 20090630-5201.
    Comment Date: 5 p.m. Eastern Time on Tuesday, July 21, 2009.

    Docket Numbers: ER09-978-001.
    Applicants: PJM Interconnection L.L.C.
    Description: PJM Interconnection submits Substitute First Revised
Sheet 224Q et al. to FERC Electric Tariff, Sixth Revised Volume 1.
    Filed Date: 07/08/2009.
    Accession Number: 20090709-0143.
    Comment Date: 5 p.m. Eastern Time on Wednesday, July 29, 2009.

    Docket Numbers: ER09-1421-000.
    Applicants: Midwest Independent Transmission System Operator, Inc.
    Description: Midwest Independent Transmission System Operator, Inc
submits Contract for Interconnection, Load Control Boundary, and
Maintenance with Northern States Power Co dated 6/12/09 etc.
    Filed Date: 07/08/2009.
    Accession Number: 20090709-0144.
    Comment Date: 5 p.m. Eastern Time on Wednesday, July 29, 2009.

    Docket Numbers: ER09-1422-000.
    Applicants: Midwest Independent Transmission System Operator, Inc.
    Description: Midwest Independent Transmission System Operator, Inc
submits a Facilities Construction Agreement with Minnkota Power
Cooperative, Inc etc.
    Filed Date: 07/08/2009.
    Accession Number: 20090709-0147.
    Comment Date: 5 p.m. Eastern Time on Wednesday, July 29, 2009.

    Any person desiring to intervene or to protest in any of the above
proceedings must file in accordance with Rules 211 and 214 of the
Commission's Rules of Practice and Procedure (18 CFR 385.211 and
385.214) on or before 5 p.m. Eastern time on the specified comment
date. It is not necessary to separately intervene again in a subdocket
related to a compliance filing if you have previously intervened in the
same docket. Protests will be considered by the Commission in
determining the appropriate action to be taken, but will not serve to
make protestants parties to the proceeding. Anyone filing a motion to
intervene or protest must serve a copy of that document on the
Applicant. In reference to filings initiating a new proceeding,
interventions or protests submitted on or before the comment deadline
need not be served on persons other than the Applicant.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper, using the FERC Online links at http://
www.ferc.gov. To facilitate electronic service, persons with Internet
access who will eFile a document and/or be listed as a contact for an
intervenor must create and validate an eRegistration account using the
eRegistration link. Select the eFiling link to log on and submit the
intervention or protests.
    Persons unable to file electronically should submit an original and
14 copies of the intervention or protest to the Federal Energy
Regulatory Commission, 888 First St. NE., Washington, DC 20426.
    The filings in the above proceedings are accessible in the
Commission's eLibrary system by clicking on the appropriate link in the
above list. They are also available for review in the Commission's
Public Reference Room in Washington, DC. There is an eSubscription link
on the Web site that enables subscribers to receive e-mail notification
when a document is added to a subscribed dockets(s). For assistance
with any FERC Online service, please e-mail<EMAIL_ADDRESS>
or call<PHONE_NUMBER> (toll free). For TTY, call<PHONE_NUMBER>.

Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. E9-17220 Filed 7-20-09; 8:45 am]

BILLING CODE 6717-01-P


[Federal Register Volume 79, Number 98 (Wednesday, May 21, 2014)]
[Notices]
[Pages 29179-29180]
[FR Doc No: 2014-11702]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings 2

    Take notice that the Commission received the following electric
rate filings:

    Docket Numbers: ER14-1952-000.
    Applicants: Gridway Energy Corp.
    Description: Notice of Cancellation to be effective 5/13/2014.
    Filed Date: 5/13/14.
    Accession Number: 20140513-5085.
    Comments Due: 5 p.m. ET 6/3/14.

    Docket Numbers: ER14-1953-000.
    Applicants: PacifiCorp.
    Description: WAPA Buffalo Head Boundary Meters Agreement to be
effective 7/13/2014.
    Filed Date: 5/13/14.
    Accession Number: 20140513-5097.
    Comments Due: 5 p.m. ET 6/3/14.

    Docket Numbers: ER14-1954-000.
    Applicants: ISO New England Inc.
    Description: 1st Quarter 2014 Capital Budget Report of ISO New
England Inc.
    Filed Date: 5/13/14.
    Accession Number: 20140513-5129.
    Comments Due: 5 p.m. ET 6/3/14.

    Docket Numbers: ER14-1955-000.
    Applicants: RTO Energy Trading, LLC.
    Description: RTO Energy Trading, LLC FERC Electric Tariff No. 1 to
be effective 6/27/2014.

    Filed Date: 5/13/14.
    Accession Number: 20140513-5175.
    Comments Due: 5 p.m. ET 6/3/14.

    The filings are accessible in the Commission's eLibrary system by
clicking on the links or querying the docket number.
    Any person desiring to intervene or protest in any of the above
proceedings must file in accordance with Rules 211 and 214 of the
Commission's Regulations (18 CFR 385.211 and 385.214) on or before 5:00
p.m. Eastern time on the specified comment date. Protests may be
considered, but intervention is necessary to become a party to the
proceeding.
    eFiling is encouraged. More detailed information relating to filing
requirements, interventions, protests, service, and qualifying
facilities filings can be found at: http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other information, call<PHONE_NUMBER>
(toll free). For TTY, call<PHONE_NUMBER>.

    Dated: May 13, 2014.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2014-11702 Filed 5-20-14; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 79, Number 46 (Monday, March 10, 2014)]
[Rules and Regulations]
[Pages 13216-13218]
[FR Doc No: 2014-05057]

=======================================================================
-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

17 CFR Part 232

[Release Nos. 33-9554; 34-71643; 39-2496; IC-30972]

Adoption of Updated EDGAR Filer Manual

AGENCY: Securities and Exchange Commission.

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: The Securities and Exchange Commission (the Commission) is
adopting revisions to the Electronic Data Gathering, Analysis, and
Retrieval System (EDGAR) Filer Manual and related rules to reflect
updates to the EDGAR system. The revisions are being made primarily to
introduce new submission form types MA, MA-A, MA/A, MA-I, MA-I/A, and
MA-W to support Registration of Municipal Advisors; updates to
submission form types 8-K, 8-K/A, 10-K, 10-K/A, 10-KT, 10-KT/A, 10-D,
10-D/A, POS AM, 424B1, 424B2, 424B3, 424B4, 424B5, 424B7, and 424B8;
and minor updates to Form 13F validations. The EDGAR system is
scheduled to be upgraded to support this functionality on March 3,
2014.

DATES: Effective Date: March 10, 2014. The incorporation by reference
of the EDGAR Filer Manual is approved by the Director of the Federal
Register as of March 10, 2014.

FOR FURTHER INFORMATION CONTACT: In the Office of Municipal Securities,
for questions concerning Registration of Municipal Advisors contact
Jessica Kane at<PHONE_NUMBER>; in the Division of Investment
Management, for questions concerning Form 13F contact Heather Fernandez
at<PHONE_NUMBER>; and in the Office of Information Technology, contact
Vanessa Anderson at<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION: We are adopting an updated EDGAR Filer
Manual, Volume I and Volume II. The Filer Manual describes the
technical formatting requirements for the preparation and submission of
electronic filings through the EDGAR system.\1\ It also describes the

requirements for filing using EDGARLink Online and the Online Forms/XML
Web site.
---------------------------------------------------------------------------

    \1\ We originally adopted the Filer Manual on April 1, 1993,
with an effective date of April 26, 1993. Release No. 33-6986 (April
1, 1993) [58 FR 18638]. We implemented the most recent update to the
Filer Manual on September 25, 2013. See Release No. 33-9457 (October
2, 2013) [78 FR 60684].
---------------------------------------------------------------------------

    The revisions to the Filer Manual reflect changes within Volume I
entitled EDGAR Filer Manual, Volume I: ``General Information,'' Version
16 (March 2014) and Volume II entitled EDGAR Filer Manual, Volume II:
``EDGAR Filing,'' Version 26 (March 2014). The updated manual will be
incorporated by reference into the Code of Federal Regulations.
    The Filer Manual contains all the technical specifications for
filers to submit filings using the EDGAR system. Filers must comply
with the applicable provisions of the Filer Manual in order to assure
the timely acceptance and processing of filings made in electronic
format.\2\ Filers may consult the Filer Manual in conjunction with our
rules governing mandated electronic filing when preparing documents for
electronic submission.\3\
---------------------------------------------------------------------------

    \2\ See Rule 301 of Regulation S-T (17 CFR 232.301).
    \3\ See Release No. 33-9457 in which we implemented EDGAR
Release 13.3. For additional history of Filer Manual rules, please
see the cites therein.
---------------------------------------------------------------------------

    The EDGAR system will be upgraded to Release 14.0 on March 3, 2014
and will introduce the following changes: EDGAR will be updated to add
new submission form types MA, MA-A, MA/A, MA-I, MA-I/A, and MA-W on the
EDGAR Filing Web site. These submission form types can be accessed by
selecting the `File Municipal Advisor Forms' link available on the
EDGAR Filing Web site. Instructions to file the Municipal Advisor Forms
are included in two new sections of Chapter 9 (Preparing and
Transmitting Online Submissions) of the ``EDGAR Filer Manual, Volume
II: EDGAR Filing'' to guide filers through the filing process. See
Release No. 34-70462 \4\ for the compliance dates.
---------------------------------------------------------------------------

    \4\ See Release No. 34-70462 (September 20, 2013) [78 FR 67467
(November 12, 2013)].
---------------------------------------------------------------------------

    Submission form types 8-K, 8-K/A, 10-K, 10-K/A, 10-KT, 10-KT/A, 10-
D, 10-D/A, POS AM, 424B1, 424B2, 424B3, 424B4, 424B5, 424B7, and 424B8
will be updated to collect Depositor CIK, Sponsor CIK, ABS Asset Class,
and ABS Sub Asset Class information for filings where the primary
registrant CIK is designated as an Asset-Backed Securities issuing
entity (i.e., entities assigned the Standard Industrial Classification
Code 6189).
    Submission form types 13F-HR/A will be updated to allow a future
date for the ``Date denied or on which confidential treatment expired''
field.
    For EDGARLink Online application, recommended version for Firefox
browser is being changed from 3.5 to 17.0 or higher. For all EDGAR Web
sites, Microsoft Internet Explorer 7.0 or later is the recommended
browser. Additionally, minor documentation only corrections were made
to the Chapter 6, Interactive Data, sections 6.5.20 and 6.6.29.
    Along with the adoption of the Filer Manual, we are amending Rule
301 of Regulation S-T to provide for the incorporation by reference
into the Code of Federal Regulations of today's revisions. This
incorporation by reference was approved by the Director of the Federal
Register in accordance with 5 U.S.C. 552(a) and 1 CFR Part 51.
    You may obtain paper copies of the updated Filer Manual at the
following address: Public Reference Room, U.S. Securities and Exchange
Commission, 100 F Street NE., Room 1543, Washington, DC 20549, on
official business days between the hours of 10:00 a.m. and 3:00 p.m. We
will post electronic format copies on the Commission's Web site; the
address for the Filer Manual is http://www.sec.gov/info/edgar.shtml.
    Since the Filer Manual and the corresponding rule changes relate
solely to agency procedures or practice, publication for notice and
comment is not required under the Administrative Procedure Act
(APA).\5\ It follows that the requirements of the Regulatory
Flexibility Act \6\ do not apply.
---------------------------------------------------------------------------

    \5\ 5 U.S.C. 553(b).
    \6\ 5 U.S.C. 601-612.
---------------------------------------------------------------------------

    The effective date for the updated Filer Manual and the rule
amendments is March 10, 2014. In accordance with the APA,\7\ we find
that there is good cause to establish an effective date less than 30
days after publication of these rules. The EDGAR system upgrade to
Release 14.0 is scheduled to become available on March 3, 2014. The
Commission believes that establishing an effective date less than 30
days after publication of these rules is necessary to coordinate the
effectiveness of the updated Filer Manual with the system upgrade.
---------------------------------------------------------------------------

    \7\ 5 U.S.C. 553(d)(3).
---------------------------------------------------------------------------

Statutory Basis

    We are adopting the amendments to Regulation S-T under Sections 6,
7, 8, 10, and 19(a) of the Securities Act of 1933,\8\ Sections 3, 12,
13, 14, 15, 23, and 35A of the Securities Exchange Act of 1934,\9\
Section 319 of the Trust Indenture Act of 1939,\10\ and Sections 8, 30,
31, and 38 of the Investment Company Act of 1940.\11\
---------------------------------------------------------------------------

    \8\ 15 U.S.C. 77f, 77g, 77h, 77j, and 77s(a).
    \9\ 15 U.S.C. 78c, 78l, 78m, 78n, 78o, 78w, and 78ll.
    \10\ 15 U.S.C. 77sss.
    \11\ 15 U.S.C. 80a-8, 80a-29, 80a-30, and 80a-37.
---------------------------------------------------------------------------

List of Subjects in 17 CFR Part 232

    Incorporation by reference, Reporting and recordkeeping
requirements, Securities.

Text of the Amendment

    In accordance with the foregoing, Title 17, Chapter II of the Code
of Federal Regulations is amended as follows:

PART 232--REGULATION S-T--GENERAL RULES AND REGULATIONS FOR
ELECTRONIC FILINGS

0
1. The authority citation for Part 232 continues to read in part as
follows:

    Authority: 15 U.S.C. 77f, 77g, 77h, 77j, 77s(a), 77z-3,
77sss(a), 78c(b), 78l, 78m, 78n, 78o(d), 78w(a), 78ll, 80a-6(c),
80a-8, 80a-29, 80a-30, 80a-37, and 7201 et seq.; and 18 U.S.C. 1350.
* * * * *

0
2. Section 232.301 is revised to read as follows:

Sec.  232.301  EDGAR Filer Manual.

    Filers must prepare electronic filings in the manner prescribed by
the EDGAR Filer Manual, promulgated by the Commission, which sets out
the technical formatting requirements for electronic submissions. The
requirements for becoming an EDGAR Filer and updating company data are
set forth in the updated EDGAR Filer Manual, Volume I: ``General
Information,'' Version 16 (March 2014). The requirements for filing on
EDGAR are set forth in the updated EDGAR Filer Manual, Volume II:
``EDGAR Filing,'' Version 26 (March 2014). Additional provisions
applicable to Form N-SAR filers are set forth in the EDGAR Filer
Manual, Volume III: ``N-SAR Supplement,'' Version 2 (August 2011). All
of these provisions have been incorporated by reference into the Code
of Federal Regulations, which action was approved by the Director of
the Federal Register in accordance with 5 U.S.C. 552(a) and 1 CFR Part
51. You must comply with these requirements in order for documents to
be timely received and accepted. You can obtain paper copies of the
EDGAR Filer Manual from the following address: Public Reference Room,
U.S. Securities and Exchange Commission, 100 F Street NE., Room 1543,
Washington, DC

20549, on official business days between the hours of 10:00 a.m. and
3:00 p.m. Electronic copies are available on the Commission's Web site.
The address for the Filer Manual is http://www.sec.gov/info/edgar.shtml. You can also inspect the document at the National Archives
and Records Administration (NARA). For information on the availability
of this material at NARA, call<PHONE_NUMBER>, or go to: http://www.archives.gov/federal_register/code_of_federal_regulations/ibr_locations.html.

    Dated: March 4, 2014.

    By the Commission.
Elizabeth M. Murphy,
Secretary.
[FR Doc. 2014-05057 Filed 3-7-14; 8:45 am]
BILLING CODE 8011-01-P


[Federal Register Volume 85, Number 243 (Thursday, December 17, 2020)]
[Notices]
[Pages 82027-82028]
[FR Doc No: 2020-27735]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Railroad Administration

[Docket Number FRA-2020-0093]

Petition for Waiver of Compliance

    Under part 211 of title 49 Code of Federal Regulations (CFR), this
document provides the public notice that on December 2, 2020, the
Brotherhood of Locomotive Engineers and Trainmen (BLET) and the
Transportation Division of the International Association of Sheet
Metal, Air, Rail, and Transportation Workers (SMART TD) petitioned the
Federal Railroad Administration (FRA) for a waiver of compliance from
certain provisions of the Federal railroad safety regulations contained
at 49 CFR parts 240 and 242. FRA assigned the petition Docket Number
FRA-2020-0093.
    Paragraphs (c) and (d) of Sec.  240.403 require petitions seeking
review of a railroad's decision to deny or revoke a locomotive
engineer's certification or recertification to be filed with FRA no
more than 180 or 120 days, respectively, after the date of a railroad's
decision. Paragraph (c) of Sec.  242.503 requires petitions seeking
review of a railroad's decision to revoke a conductor's certification
to be filed with FRA no more than 120 days after a railroad's decision.
Due to the coronavirus disease 2019 (COVID-19) public health emergency,
FRA granted relief by letter dated April 7, 2020, and renewed that
relief on June 3, 2020, July 30, 2020, and September 24, 2020. BLET and
SMART TD once again request to renew this emergency relief. In light of
the continued renewal requests, FRA now considers whether longer-term
relief is necessary.
    In support of their initial March 30, 2020, request for relief,
petitioners noted FRA's March 25, 2020, waiver from certain
requirements of 49 CFR parts 240 and 242 related to deadlines for
responding to petitions submitted to FRA's Operating Crew Review Board
granted to the Association of American Railroads, the American Short
Line and Regional Railroad Association, and the American Public
Transportation Association (together referred to as the

Associations).\1\ BLET and SMART TD asserted that, as a result of the
COVID-19 public health emergency, they and their members face ``even
greater difficulty in timely filing petitions for review'' than the
Associations and their members will have in responding to those
petitions. In requesting a fourth renewal, the petitioners explain they
``continue to experience uncertainty of staff availability during [the]
COVID-19 emergency'' and the resulting negative impact on their ability
to gather additional relevant information and to draft proper petitions
within the normal required time frames. FRA opened this docket to
evaluate whether the requested emergency relief is necessary on a more
long-term basis, similar to the Associations' requests.
---------------------------------------------------------------------------

    \1\ On September 18, 2020, FRA renewed each Association's
request for relief in separate, non-emergency dockets. See https://www.regulations.gov/document?D=FRA-2020-0059-0004; https://www.regulations.gov/document?D=FRA-2020-0060-0005; and https://www.regulations.gov/document?D=FRA-2020-0063-0003.
_____________________________________-

    A copy of the petition, as well as any written communications
concerning the petition, is available for review online at
www.regulations.gov (Docket Number FRA-2020-0093).
    Interested parties are invited to participate in these proceedings
by submitting written views, data, or comments. If any interested
parties desire an opportunity for oral comment and a public hearing,
they should notify FRA, in writing, before the end of the comment
period and specify the basis for their request.
    All communications concerning these proceedings should identify the
appropriate docket number and may be submitted at http://www.regulations.gov. Follow the online instructions for submitting
comments.
    Communications received by January 19, 2021 will be considered by
FRA before final action is taken. Comments received after that date
will be considered if practicable. Anyone can search the electronic
form of any written communications and comments received into any of
our dockets by the name of the individual submitting the comment (or
signing the document, if submitted on behalf of an association,
business, labor union, etc.). Under 5 U.S.C. 553(c), the U.S.
Department of Transportation (DOT) solicits comments from the public to
better inform its processes. DOT posts these comments, without edit,
including any personal information the commenter provides, to
www.regulations.gov, as described in the system of records notice (DOT/
ALL-14 FDMS), which can be reviewed at https://www.transportation.gov/privacy. See also https://www.regulations.gov/privacyNotice for the
privacy notice of regulations.gov.

    Issued in Washington, DC.
John Karl Alexy,
Associate Administrator for Railroad Safety. Chief Safety Officer.
[FR Doc. 2020-27735 Filed 12-16-20; 8:45 am]
BILLING CODE 4910-06-P


[Federal Register: May 10, 2010 (Volume 75, Number 89)]
[Notices]
[Page 25854-25855]
[DOCID:fr10my10-47]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OECA-2009-0542; FRL-9148-7]

Agency Information Collection Activities; Submission to OMB for
Review and Approval; Comment Request; Emissions Guidelines for
Commercial and Industrial Solid Waste Incineration Units (Renewal), EPA
ICR Number 1927.05, OMB Control Number 2060-0451

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In compliance with the Paperwork Reduction Act (44 U.S.C. 3501
et seq.), this document announces that an Information Collection
Request (ICR) has been forwarded to the Office of Management and Budget
(OMB) for review and approval. This is a request to renew an existing
approved collection. The ICR which is abstracted below describes the
nature of the collection and the estimated burden and cost.

DATES: Additional comments may be submitted on or before June 9, 2010.

ADDRESSES: Submit your comments, referencing docket ID number EPA-HQ-
OECA-2009-0542, to (1) EPA online using http://www.regulations.gov (our
preferred method), or by e-mail to<EMAIL_ADDRESS>or by mail to:
EPA Docket Center (EPA/DC), Environmental Protection Agency,
Enforcement and Compliance Docket and Information Center, mail code
28221T, 1200 Pennsylvania Avenue, NW., Washington, DC 20460, and (2)
OMB at: Office of Information and Regulatory Affairs, Office of
Management and Budget (OMB), Attention: Desk Officer for EPA, 725 17th
Street, NW., Washington, DC 20503.

FOR FURTHER INFORMATION CONTACT: Robert C. Marshall, Jr., Office of
Compliance, Mail code: 2223A, Environmental Protection Agency, 1200
Pennsylvania Avenue, NW., Washington, DC 20460; telephone number: (202)
564-7021; fax number:<PHONE_NUMBER>; e-mail address:
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: EPA has submitted the following ICR to OMB
for review and approval according to the procedures prescribed in 5 CFR
1320.12. On July 30, 2009 (74 FR 38005), EPA sought comments on this
ICR pursuant to 5 CFR 1320.8(d). EPA received no comments. Any
additional comments on this ICR should be submitted to EPA and OMB
within 30 days of this notice.
    EPA has established a public docket for this ICR under docket ID
number EPA-HQ-OECA-2009-0542, which is available for public viewing
online at http://www.regulations.gov, in person viewing at the
Enforcement and Compliance Docket in the EPA Docket Center (EPA/DC),
EPA West, Room 3334, 1301 Constitution Avenue, NW., Washington, DC. The
EPA Docket Center Public Reading Room is open from 8:30 a.m. to 4:30
p.m., Monday through Friday, excluding legal holidays. The telephone
number for the Reading Room is<PHONE_NUMBER>, and the telephone number
for the Enforcement and Compliance Docket is<PHONE_NUMBER>.
    Use EPA's electronic docket and comment system at http://
www.regulations.gov, to submit or view public comments, access the
index listing of the contents of the docket, and to access those
documents in the docket that are available electronically. Once in the
system, select ``docket search,'' then key in the docket ID number
identified above. Please note that EPA's policy is that public
comments, whether submitted electronically or in paper, will be made
available for public viewing at http://www.regulations.gov, as EPA
receives them and without change, unless the comment contains
copyrighted material, Confidential Business Information (CBI), or other
information whose public disclosure is restricted by statute. For
further information about the electronic docket, go to http://
www.regulations.gov.
    Title: Emissions Guidelines for Commercial and Industrial Solid
Waste Incineration Units (Renewal)
    ICR Numbers: EPA ICR Number 1927.05, OMB Control Number 2060-0451.
    ICR Status: This ICR is scheduled to expire on June 30, 2010. Under
OMB regulations, the Agency may continue to conduct or sponsor the
collection of information while this submission is pending at OMB. An
Agency may not conduct or sponsor, and a person is not required to
respond to, a collection of information unless it displays a currently
valid OMB control number. The OMB control numbers for EPA's regulations
in title 40 of the CFR, after appearing in the Federal Register when
approved, are listed in 40 CFR part 9, and displayed either by
publication in the Federal Register or by other appropriate means, such
as on the related collection instrument or form, if applicable. The
display of OMB control numbers in certain EPA regulations is
consolidated in 40 CFR part 9.
    Abstract: The Emission Guidelines for Commercial and Industrial
Solid Waste Incineration (CISWI) Units were promulgated on December 1,
2000. The guidelines (standards) apply to solid waste incinerators in
40 CFR part 60, subpart DDDD. These standards fulfill the requirements
of sections 111 and 129 of the Clean Air Act (CAA). This subpart
affects the administrator of an air quality program in a state, or
United States protectorate with one or more existing CISWI units that
commenced construction either on, or before, November 30, 1999.
    Burden Statement: The annual public reporting and recordkeeping
burden for this collection of information is estimated to average 232
hours per response. Burden means the total time, effort, or financial
resources expended by persons to generate, maintain, retain, or
disclose or provide information to or for a Federal agency. This
includes the time needed to review instructions; develop, acquire,
install, and utilize technology and systems for the purposes of
collecting, validating, and verifying information, processing and
maintaining information, and disclosing and providing information;
adjust the existing ways to comply with any previously applicable
instructions and requirements which have subsequently changed; train
personnel to be able to respond to a collection of information; search
data sources; complete and review the collection of information; and
transmit or otherwise disclose the information.
    Respondents/Affected Entities: Commercial and industrial solid
waste incineration units.
    Estimated Number of Respondents: 97.
    Frequency of Response: Initially, occasionally, semiannually and
annually.
    Estimated Total Annual Hour Burden: 31,619.
    Estimated Total Annual Cost: $2,904,577, which includes $2,884,110
in labor costs, no capital/startup costs, and $20,467 in operation and
maintenance (O&M) costs.
    Changes in the Estimates: There is no change in the cost to the
respondents in this ICR compared to the previous ICR. This is due to
two considerations: (1) The regulations have not changed over the past
three years and are not anticipated to change over the next three
years; and (2) the growth rate for the respondents is very low,
negative or non-existent. Therefore, the cost figures in the previous
ICR reflect the current burden to the respondents and are reiterated in
this ICR. However, there is a decrease of one hour in the total labor
hours to the respondent in this ICR due to rounding.
    In accordance with the Paperwork Reduction Act, actions related to
case development activities have been removed from the Agency cost
figures. Therefore, the cost to the Agency as reported in this ICR has
been reduced from $87,648.00 to $46,463.00

    Dated: May 4, 2010.
John Moses,
Director, Collection Strategies Division.
[FR Doc. 2010-11001 Filed 5-7-10; 8:45 am]
BILLING CODE 6560-50-P


[Federal Register Volume 80, Number 87 (Wednesday, May 6, 2015)]
[Notices]
[Pages 26059-26061]
[FR Doc No: 2015-10477]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2015-N-1419]

Withdrawal of Draft Guidance Documents Published Before December
31, 2013

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the
withdrawal of 47 draft guidance documents that published before
December 31, 2013, and have never been finalized. FDA is taking this
action to improve the efficiency and transparency of the guidance
development process.

DATES: Although you can comment on any guidance at any time (see 21 CFR
10.115(g)(5)), if you wish to submit comments on a specific withdrawal
action in this notice, submit either electronic or written comments by
June 5, 2015.

ADDRESSES: You may submit comments by any of the following methods:

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: http://www.regulations.gov.
Follow the instructions for submitting comments.

Written Submissions

    Submit written submissions in the following ways:
     Mail/Hand delivery/Courier (for paper submissions):
Division of Dockets Management (HFA-305), Food and Drug Administration,
5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
    Instructions: All submissions received must include the Docket No.
FDA-2015-N-1419 for this action. All comments received may be posted
without change to http://www.regulations.gov, including any personal
information provided.
    Docket: For access to the docket to read background documents or
comments received, go to http://www.regulations.gov and insert the
docket number(s), found in brackets in the heading of this document,
into the ``Search'' box and follow the prompts and/or go to the
Division of Dockets Management, 5630 Fishers Lane, Rm. 1061, Rockville,
MD 20852.

FOR FURTHER INFORMATION CONTACT: Lisa M. Helmanis, Regulations Policy
and Management Staff, Office of the Commissioner, Food and Drug
Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 3326, Silver
Spring, MD 20993-0002,<PHONE_NUMBER>, email<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. Background

    In September 2000, FDA codified its good guidance practices (GGPs).
GGPs are FDA's policies and procedures for the development, issuance,
and use of guidance documents. Level I guidance documents set forth
initial interpretations of statutory or regulatory requirements,
explain changes in interpretation of policies, or discuss complex
scientific issues or highly controversial issues. The GGPs, generally,
require that such guidances be issued in draft for public comment
before they are finalized. FDA's guidance documents do not create

legally enforceable rights or responsibilities and do not legally bind
the public or FDA.
    A key component of the GGPs is ensuring transparency during
guidance development and issuance. In 2011, as part of the Agency's
Transparency Initiative, FDA reviewed and set forth best practices for
facilitating early stakeholder input, efficiency, and transparency in
the Agency's processes, including GGPs.
    In recent years, FDA's guidance workload has increased due to
requests from the public for guidance to clarify specific issues and
statutorily mandated guidances. Many of these draft guidances were not
finalized most often because of higher priorities and resource issues.
However, over the years, because of new information, scientific
developments, and emerging technologies, a number of draft guidances
have become outdated and therefore, should be withdrawn.

II. Withdrawal of Guidances

    FDA is withdrawing the following 47 guidance documents.

----------------------------------------------------------------------------------------------------------------
                Draft guidance                                    Docket No.                    Publication date
----------------------------------------------------------------------------------------------------------------
1. Draft Guidance for Industry: Platelet        FDA-1998-D-0680                                        5/20/1999
 Testing and Evaluation of Platelet Substitute
 Products.
2. Draft Guidance for Industry: Precautionary   FDA-1999-D-0045                                        2/11/2002
 Measures to Reduce the Possible Risk of
 Transmission of Zoonoses by Blood and Blood
 Products from Xenotransplantation Product
 Recipients and Their Intimate Contacts.
3. Draft Guidance for Industry: Criteria for    FDA-2004-D-0420                                       10/28/2004
 Safety and Efficacy Evaluation of Oxygen
 Therapeutics as Red Blood Cell Substitutes.
4. Draft Guidance for Industry: Validation of   FDA-2008-D-0055                                        2/11/2008
 Growth-Based Rapid Microbiological Methods
 for Sterility Testing of Cellular and Gene
 Therapy Products.
5. Draft Guidance for Industry: Use of          FDA-2009-D-0137                                        3/26/2009
 Serological Tests to Reduce the Risk of
 Transmission of Trypanosoma cruzi Infection
 in Whole Blood and Blood Components for
 Transfusion and Human Cells, Tissues, and
 Cellular and Tissue-Based Products (HCT/Ps).
6. Accelerated Approval Products--Submission    FDA-1999-D-0752                                        3/26/1999
 of Promotional Materials.
7. Providing Regulatory Submissions in          FDA-2001-D-0169                                         1/1/2001
 Electronic Format--Prescription Drug
 Advertising and Promotional Labeling.
8. Comparability Protocols--Protein Drug        FDA-2003-D-0355                                         9/5/2003
 Products and Biological Products--Chemistry,
 Manufacturing, and Controls Information.
9. Providing Regulatory Submissions in          FDA-2003-D-0429                                        10/1/2003
 Electronic Format--General Considerations.
10. ``Help-Seeking'' and Other Disease          FDA-2004-D-0500                                        1/26/2004
 Awareness Communications by or on Behalf of
 Drug and Device Firms.
11. Notification to FDA of Issues that May      FDA-2012-D-0140                                        2/21/2012
 Result in a Prescription Drug or Biological
 Product Shortage.
12. Assessing the Safety and Effectiveness of   FDA-1998-N-0050                                        10/5/1988
 Home-Use In Vitro Diagnostic Devices: Draft
 Points to Consider Regarding Labeling and
 Premarket Submissions.
13. 510(k) Submission of Lymphocyte             FDA-1998-N-0050                                        9/26/1991
 Immunophenotyping IVDs Using Monoclonal        FDA-2013-N-0046
 Antibodies.
14. 510(k) Submission of Immunoglobulins A, G,  FDA-1998-N-0050                                         9/1/1992
 M, D, and E Immunoglobulin System In Vitro
 Devices.
15. Draft Guidance for Preparation of PMA       FDA-1998-N-0050                                        3/16/1993
 Applications for Testicular Prostheses.
16. Emergency Resuscitator Guidance...........  FDA-1998-N-0050                                        4/14/1993
17. 510(k) Submission Requirements for Peak     FDA-1998-N-0050                                         1/3/1994
 Flow Meters.
18. Reviewer Guidance on Face Masks and Shield  FDA-1998-N-0050                                        3/16/1994
 for CPR.
19. Reviewer Guidance for Ventilators.........  FDA-1998-N-0050                                         7/1/1995
20. Testing MR Interaction with Aneurysm Clips  FDA-1998-N-0050                                        5/22/1996
21. A Primer on Medical Device Interactions     FDA-1997-D-0423                                         2/7/1997
 with Magnetic Resonance Imaging Systems.
22. Review Criteria Assessment of Portable      FDA-2006-P-0022-0003                                   2/28/1997
 Blood Glucose Monitoring In Vitro Diagnostic
 Devices Using Glucose Oxidase, Dehydrogenase
 or Hexokinase Methodology.
23. Distribution and Public Availability of     FDA-1998-N-0050-0002                                  10/10/1997
 Premarket Approval Application Summary of
 Safety and Effectiveness Data Packages (P97-
 1).
24. Premarket Submissions and Labeling          FDA-2003-D-0373                                        12/2/2003
 Recommendations for Drugs of Abuse Screening
 Tests.
25. Class II Special Controls Guidance          FDA-2005-D-0085                                        11/8/2005
 Document: Tinnitus Masker Devices.
26. Class II Special Controls Guidance          FDA-2006-D-0356                                       10/31/2006
 Document: Absorbable Hemostatic Device.
27. Class II Special Controls Guidance          FDA-2008-D-0603                                       12/22/2008
 Document: Tissue Expander.
28. Heart Valves: Investigational Device        FDA-2009-D-0559                                        1/20/2010
 Exemption and Premarket Approval Applications.
29. Class II Special Controls Guidance          FDA-2009-D-0495                                         4/5/2010
 Document: Electroconductive Media.
30. Class II Special Controls Guidance          FDA-2009-D-0495                                         4/5/2010
 Document: Cutaneous Electrode.
31. Class II Special Controls Guidance          FDA-2009-D-0495                                         4/5/2010
 Document: Transcutaneous Electrical Nerve
 Stimulator for Pain Relief.
32. Class II Special Controls Guidance          FDA-2009-D-0495                                         4/5/2010
 Document: Transcutaneous Electrical Nerve
 Stimulator with Limited Output for Pain
 Relief.
33. Class II Special Controls Guidance          FDA-2009-D-0495                                         4/5/2010
 Document: Transcutaneous Electrical
 Stimulator for Aesthetic Purposes.
34. Class II Special Controls Guidance          FDA-2009-D-0495                                         4/5/2010
 Document: Transcutaneous Electrical
 Stimulator with Limited Output for Aesthetic
 Purposes.
35. Class II Special Controls Guidance          FDA-2009-D-0495                                         4/5/2010
 Document: Powered Muscle Stimulator for
 Rehabilitation.
36. Class II Special Controls Guidance          FDA-2009-D-0495                                         4/5/2010
 Document: Powered Muscle Stimulator with
 Limited Output for Rehabilitation.
37. Class II Special Controls Guidance          FDA-2009-D-0495                                         4/5/2010
 Document: Powered Muscle Stimulator for
 Muscle Conditioning.
38. Class II Special Controls Guidance          FDA-2009-D-0495                                         4/5/2010
 Document: Powered Muscle Stimulator with
 Limited Output for Muscle Conditioning.
39. Class II Special Controls Guidance          FDA-2009-D-0495                                         4/5/2010
 Document: Transcutaneous Electrical Nerve
 Stimulator for Pain Relief Intended for Over
 the Counter Use.

40. Recommended Warning for Surgeon's Gloves    FDA-2011-D-0030                                         2/7/2011
 and Patient Examination Gloves.
41. Class II Special Controls Guidance          FDA-2011-D-0102                                        5/18/2011
 Document: In Vitro Diagnostic Devices for
 Bacillus spp. Detection.
42. Use of Antibiotic Resistance Marker Genes   FDA-1998-N-0050                                         9/4/1998
 in Transgenic Plants.
43. Drugs, Biologics, and Medical Devices       FDA-2002-D-0135                                        9/11/2002
 Derived from Bioengineered Plants for Use in
 Humans and Animals.
44. Preliminary Timetable for the Review of     FDA-2009-D-0563                                       11/27/2009
 Applications for Modified Risk Tobacco
 Products under the Federal Food, Drug, and
 Cosmetic Act.
45. Guidance for Industry: Regulatory           FDA-1998-N-0050                                        11/5/2002
 Procedures Manual--Chapter 9, Subchapter:
 Guidance Concerning Recommending Customs'
 Seizure and Destruction of Imported Human and
 Animal Food That has Not Been Reconditioned;
 Draft Guidance.
46. Submission of Laboratory Packages By        FDA-2008-D-0510                                           1/2009
 Accredited Laboratories.
47. Guidance for the Public and FDA Staff on    FDA-2008-D-0417                                         8/1/2008
 Convening Advisory Committee Meetings.
----------------------------------------------------------------------------------------------------------------

    Dated: April 30, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015-10477 Filed 5-5-15; 8:45 am]
BILLING CODE 4164-01-P


[Federal Register Volume 86, Number 108 (Tuesday, June 8, 2021)]
[Notices]
[Pages 30508-30510]
[FR Doc No: 2021-11912]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-92090; File No. SR-MIAX-2021-22]

Self-Regulatory Organizations; Miami International Securities
Exchange, LLC; Notice of Filing and Immediate Effectiveness of a
Proposed Rule Change To Delay Implementation of an Amendment to Rule
518, Complex Orders, To Permit Legging Through the Simple Market

June 2, 2021.
    Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934
(``Act''),\1\ and Rule 19b-4 thereunder,\2\ notice is hereby given that
on May 21, 2021, Miami International Securities Exchange, LLC (``MIAX
Options'' or the ``Exchange'') filed with the Securities and Exchange
Commission (``Commission'') the proposed rule change as described in
Items I, II, and III below, which Items have been prepared by the
Exchange. The Exchange filed the proposed rule change pursuant to
Section 19(b)(3)(A)(iii) of the Act \3\ and Rule 19b-4(f)(6)
thereunder.\4\ The Commission is publishing this notice to solicit
comments on the proposed rule change from interested persons.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
    \3\ 15 U.S.C. 78s(b)(3)(A)(iii).
    \4\ 17 CFR 240.19b-4(f)(6).
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change

    The Exchange is filing a proposal to delay implementation of the
change to allow a component of a complex order \5\ that legs into the
Simple Order Book \6\ to execute at a price that is outside the
NBBO.\7\
---------------------------------------------------------------------------

    \5\ A ``complex order'' is any order involving the concurrent
purchase and/or sale of two or more different options in the same
underlying security (the ``legs'' or ``components'' of the complex
order), for the same account, in a ratio that is equal to or greater
than one-to-three (.333) and less than or equal to three-to-one
(3.00) and for the purposes of executing a particular investment
strategy. Mini-options may only be part of a complex order that
includes other mini-options. Only those complex orders in the
classes designated by the Exchange and communicated to Members via
Regulatory Circular with no more than the applicable number of legs,
as determined by the Exchange on a class-by-class basis and
communicated to Members via Regulatory Circular, are eligible for
processing. See Exchange Rule 518(a)(5).
    \6\ The ``Simple Order Book'' is the Exchange's regular
electronic book of orders and quotes. See Exchange Rule 518(a)(15).
    \7\ The term ``NBBO'' means the national best bid or offer as
calculated by the Exchange based on market information received by
the Exchange from the appropriate Securities Information Processor
(``SIP''). See Exchange Rule 518(a)(14).
---------------------------------------------------------------------------

    The text of the proposed rule change is available on the Exchange's
website at http://www.miaxoptions.com/rule-filings/ at MIAX Options'
principal office, and at the Commission's Public Reference Room.

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, the Exchange included statements
concerning the purpose of and basis for the proposed rule change and
discussed any comments it received on the proposed rule change. The
text of these statements may be examined at the places specified in
Item IV below. The Exchange has prepared summaries, set forth in
sections A, B, and C below, of the most significant aspects of such
statements.

A. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

1. Purpose
    On October 22, 2019, the Exchange filed a proposed rule change to
amend subsection (c)(2)(iii) of Exchange Rule 518, Complex Orders, to
remove the provision which provides that a component of a complex order
that legs into the Simple Order Book may not execute at a price that is
outside the NBBO.\8\ The proposed rule change indicated that the
Exchange would announce the implementation date of the proposed rule
change by Regulatory Circular to be published no later than 90 days
following the operative date of the proposed rule. The implementation
date will be no later than 90 days following the issuance of the
Regulatory Circular. The Exchange delayed the implementation of this
functionality until the second quarter of 2021.\9\ The Exchange now
proposes to delay the implementation of this functionality until the
second quarter of 2022.
---------------------------------------------------------------------------

    \8\ See Securities Exchange Release No. 87440 (November 1,
2019), 84 FR 60117 (November 7, 2019) (SR-MIAX-2019-45).
    \9\ See Securities Exchange Release No. 90507 (November 24,
2020), 85 FR 77321 (December 1, 2020) (SR-MIAX-2020-36).
---------------------------------------------------------------------------

    The Exchange proposes this delay in order to allow the Exchange to
complete its reprioritization of its software delivery and release
schedule as a result of a shift in priorities due to the impact the
coronavirus pandemic has had on Exchange operations. The Exchange will
issue a Regulatory Circular notifying market participants at least 45
days prior to implementing this functionality.
2. Statutory Basis
    The Exchange believes that its proposed rule change is consistent
with Section 6(b) of the Act \10\ in general, and furthers the
objectives of Section 6(b)(5) of the Act \11\ in particular, in that it
is designed to prevent fraudulent and manipulative acts and practices,
to promote just and equitable principles of trade, to foster
cooperation and coordination with persons engaged in regulating,
clearing, settling, processing information with respect to, and
facilitating transactions in, securities, to remove impediments to and
perfect the mechanisms of a free and open market and a national market
system and, in general, to protect investors and the public interest by
allowing the Exchange additional time to plan and implement the
proposed functionality.
---------------------------------------------------------------------------

    \10\ 15 U.S.C. 78f(b).
    \11\ 15 U.S.C. 78f(b)(5).
---------------------------------------------------------------------------

B. Self-Regulatory Organization's Statement on Burden on Competition

    The Exchange does not believe that the proposed rule change will
impose any burden on competition that is not necessary or appropriate
in furtherance of the purposes of the Act. The Exchange's proposal to
delay the implementation of the proposed functionality does not impose
an undue burden on competition. Delaying the implementation will simply
allow the Exchange additional time to properly plan and implement the
proposed functionality.
    The Exchange does not believe that the proposed rule change will
impose any burden on intramarket competition as the delay will apply
equally to all Members of the Exchange.
    The Exchange does not believe that the proposed rule change will
impose any burden on intermarket competition as the proposal is to
delay the implementation of approved functionality which affects MIAX
Members only and does not impact intermarket competition.

C. Self-Regulatory Organization's Statement on Comments on the Proposed
Rule Change Received From Members, Participants, or Others

    Written comments were neither solicited nor received.

III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action

    The Exchange has filed the proposed rule change pursuant to Section
19(b)(3)(A)(iii) of the Act \12\ and Rule 19b-4(f)(6) thereunder.\13\
Because the proposed rule change does not: (i) Significantly affect the
protection of investors or the public interest; (ii) impose any
significant burden on competition; and (iii) become operative prior to
30 days from the date on which it was filed, or such shorter time as
the Commission may designate, if consistent with the protection of
investors and the public interest, the proposed rule change has become
effective pursuant to Section 19(b)(3)(A) of the Act and Rule 19b-
4(f)(6)(iii) thereunder.
---------------------------------------------------------------------------

    \12\ 15 U.S.C. 78s(b)(3)(A)(iii).
    \13\ 17 CFR 240.19b-4(f)(6).
---------------------------------------------------------------------------

    At any time within 60 days of the filing of such proposed rule
change, the Commission summarily may temporarily suspend such rule
change if it appears to the Commission that such action is necessary or
appropriate in the public interest, for the protection of investors, or
otherwise in furtherance of the purposes of the Act. If the Commission
takes such action, the Commission shall institute proceedings under
Section 19(b)(2)(B) \14\ of the Act to determine whether the proposed
rule change should be approved or disapproved.
---------------------------------------------------------------------------

    \14\ 15 U.S.C. 78s(b)(2)(B).
---------------------------------------------------------------------------

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views, and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Act. Comments may be submitted by any of
the following methods:

Electronic Comments

     Use the Commission's internet comment form (http://www.sec.gov/rules/sro.shtml); or
     Send an email to<EMAIL_ADDRESS>Please include
File Number SR-MIAX-2021-22 on the subject line.

Paper Comments

     Send paper comments in triplicate to Secretary, Securities
and Exchange Commission, 100 F Street NE, Washington, DC 20549-1090.

All submissions should refer to File Number SR-MIAX-2021-22. This file
number should be included on the subject line if email is used. To help
the Commission process and review your comments more efficiently,
please use only one method. The Commission will post all comments on
the Commission's internet website (http://www.sec.gov/rules/sro.shtml).
Copies of the submission, all subsequent amendments, all written
statements with respect to the proposed rule change that are filed with
the Commission, and all written communications relating to the proposed
rule change between the Commission and any person, other than those
that may be withheld from the public in accordance with the provisions
of 5 U.S.C. 552, will be available for website viewing and printing in
the Commission's Public Reference Room, 100 F Street, NE, Washington,
DC 20549, on official business days between the hours of 10:00 a.m. and
3:00 p.m. Copies of the filing also will be available for inspection
and copying at the principal office of the Exchange. All comments
received will be posted without change. Persons submitting comments are
cautioned that we do not redact or edit personal identifying
information from comment submissions. You should

submit only information that you wish to make available publicly. All
submissions should refer to File Number SR-MIAX-2021-22, and should be
submitted on or before June 29, 2021.

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\15\
J. Matthew DeLesDernier,
Assistant Secretary.

---------------------------------------------------------------------------

    \15\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

[FR Doc. 2021-11912 Filed 6-7-21; 8:45 am]
BILLING CODE 8011-01-P


[Federal Register: August 17, 2010 (Volume 75, Number 158)]
[Notices]
[Page 50753-50754]
[DOCID:fr17au10-37]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings

August 3, 2010.
    Take notice that the Commission has received the following Natural
Gas Pipeline Rate and Refund Report filings:
    Docket Numbers: RP06-336-000
    Applicants: Pine Needle LNG Company, LLC,
    Pine Needle LNG Company, LLC
    Description: Motion of Pine Needle LNG Company, LLC to Amend
Settlement and Request for Shortened Answer Period and Expedited
Action.
    Filed Date: 07/16/2010
    Accession Number: 20100716-5037
    Comment Date: 5 p.m. Eastern Time on Thursday, August 5, 2010.

    Docket Numbers: RP10-1030-000
    Applicants: National Fuel Gas Distribution Corporation
    Description: National Fuel Gas Supply Corporation submits their
138th Revised Sheet 9 to FERC Gas Tariff, Fourth Revised Volume 1, to
be effective 8/1/10.
    Filed Date: 07/30/2010
    Accession Number: 20100802-0209
    Comment Date: 5 p.m. Eastern Time on Wednesday, August 11, 2010.

    Docket Numbers: RP10-1031-000
    Applicants: Cimarron River Pipeline, LLC
    Description: Cimarron River Pipeline, LLC submits Third Revised
Sheet 17 to FERC Gas Tariff, Original Volume 1, and request waiver of
the provisions of Section 12.5, to be effective 9/1/10.
    Filed Date: 07/30/2010
    Accession Number: 20100802-0210
    Comment Date: 5 p.m. Eastern Time on Wednesday, August 11, 2010.

    Docket Numbers: RP10-1032-000
    Applicants: Caledonia Energy Partners, LLC
    Description: Caledonia Energy Partners, LLC submits Original Sheet
No 1 et al. to FERC Gas Tariff, First Revised Volume 1 to replace its
current tariff.

    Filed Date: 07/30/2010.
    Accession Number: 20100802-0212.
    Comment Date: 5 p.m. Eastern Time on Wednesday, August 11, 2010.

    Docket Numbers: RP10-1036-000.
    Applicants: Algonquin Gas Transmission, LLC.
    Description: Algonquin Gas Transmission, LLC submits tariff filing
per 154.204: Negotiated Rate Agreement--TGP to be effective 8/1/2010.
    Filed Date: 08/02/2010.
    Accession Number: 20100802-5068.
    Comment Date: 5 p.m. Eastern Time on Monday, August 16, 2010.

    Docket Numbers: RP10-1037-000.
    Applicants: Granite State Gas Transmission, Inc.
    Description: Request for Limited Waiver by Granite State
Transmission, Inc.
    Filed Date: 08/02/2010.
    Accession Number: 20100802-5073.
    Comment Date: 5 p.m. Eastern Time on Monday, August 16, 2010.

    Docket Numbers: RP10-1038-000.
    Applicants: Gulf South Pipeline Company, LP.
    Description: Gulf South Pipeline Company, LP submits tariff filing
per 154.204: Devon-Texla Negotiated Rate filing to be effective 8/1/
2010.
    Filed Date: 08/02/2010.
    Accession Number: 20100802-5088.
    Comment Date: 5 p.m. Eastern Time on Monday, August 16, 2010.

    Docket Numbers: RP10-1039-000.
    Applicants: Equitrans, L.P.
    Description: Equitrans' Big Sandy Pipeline Semi-Annual Retainage
Filing.
    Filed Date: 07/30/2010.
    Accession Number: 20100730-5260.
    Comment Date: 5 p.m. Eastern Time on Wednesday, August 11, 2010.

    Docket Numbers: RP10-1040-000.
    Applicants: Southern Star Central Gas Pipeline, Inc.
    Description: Southern Star Central Gas Pipeline, Inc. submits
tariff filing per 154.204: Third Party Storage 2010 to be effective 9/
1/2010.
    Filed Date: 08/02/2010.
    Accession Number: 20100802-5107.
    Comment Date: 5 p.m. Eastern Time on Monday, August 16, 2010.

    Docket Numbers: RP10-1041-000.
    Applicants: Southern LNG Inc.
    Description: Southern LNG Inc. submits tariff filing per 154.203:
SLNG Volume 1 to be effective 8/1/2010.
    Filed Date: 08/02/2010.
    Accession Number: 20100802-5131.
    Comment Date: 5 p.m. Eastern Time on Monday, August 16, 2010.

    Docket Numbers: RP10-1042-000.
    Applicants: Cheyenne Plains Gas Pipeline Company, L.L.C.
    Description: Cheyenne Plains Gas Pipeline Company, L.L.C. submits
tariff filing per 154.203: Baseline to be effective 8/2/2010.
    Filed Date: 08/02/2010.
    Accession Number: 20100802-5139.
    Comment Date: 5 p.m. Eastern Time on Monday, August 16, 2010.

    Docket Numbers: RP10-1043-000.
    Applicants: Southern Natural Gas Company.
    Description: Southern Natural Gas Company submits tariff filing per
154.203: SNG Baseline Tariff Filing to be effective 8/2/2010.
    Filed Date: 08/02/2010.
    Accession Number: 20100802-5153.
    Comment Date: 5 p.m. Eastern Time on Monday, August 16, 2010.

    Docket Numbers: RP10-1044-000.
    Applicants: MIGC LLC.
    Description: MIGC LLC submits tariff filing per 154.203: MIGC LLC
Baseline Filing to be effective 8/2/2010.
    Filed Date: 08/02/2010.
    Accession Number: 20100802-5164.
    Comment Date: 5 p.m. Eastern Time on Monday, August 16, 2010.

    Any person desiring to intervene or to protest in any of the above
proceedings must file in accordance with Rules 211 and 214 of the
Commission's Rules of Practice and Procedure (18 CFR 385.211 and
385.214) on or before 5 p.m. Eastern time on the specified comment
date. It is not necessary to separately intervene again in a subdocket
related to a compliance filing if you have previously intervened in the
same docket. Protests will be considered by the Commission in
determining the appropriate action to be taken, but will not serve to
make protestants parties to the proceeding. Anyone filing a motion to
intervene or protest must serve a copy of that document on the
Applicant. In reference to filings initiating a new proceeding,
interventions or protests submitted on or before the comment deadline
need not be served on persons other than the Applicant.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper, using the FERC Online links at http://
www.ferc.gov. To facilitate electronic service, persons with Internet
access who will eFile a document and/or be listed as a contact for an
intervenor must create and validate an eRegistration account using the
eRegistration link. Select the eFiling link to log on and submit the
intervention or protests.
    Persons unable to file electronically should submit an original and
14 copies of the intervention or protest to the Federal Energy
Regulatory Commission, 888 First St., NE., Washington, DC 20426.
    The filings in the above proceedings are accessible in the
Commission's eLibrary system by clicking on the appropriate link in the
above list. They are also available for review in the Commission's
Public Reference Room in Washington, DC. There is an eSubscription link
on the Web site that enables subscribers to receive email notification
when a document is added to a subscribed dockets(s). For assistance
with any FERC Online service, please email<EMAIL_ADDRESS>
or call<PHONE_NUMBER> (toll free). For TTY, call<PHONE_NUMBER>.

Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2010-20266 Filed 8-16-10; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register: May 29, 2008 (Volume 73, Number 104)]
[Notices]
[Page 30981-30984]
[DOCID:fr29my08-128]

=======================================================================
-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Investment Company Act Release No. 28284; 812-13475]

Matrix Capital Group, Inc. and Matrix Defined Trusts; Notice of
Application

May 22, 2008.
AGENCY: Securities and Exchange Commission (``Commission'').

ACTION: Notice of an application under (a) section 6(c) of the
Investment Company Act of 1940 (``Act'') for an exemption from sections
2(a)(32), 2(a)(35), 14(a), 19(b), 22(d) and 26(a)(2)(C) of the Act and
rules 19b-1 and rule 22c-1 thereunder and (b) sections 11(a) and 11(c)
of the Act for approval of certain exchange and rollover privileges.

-----------------------------------------------------------------------

Applicants: Matrix Capital Group, Inc. (``Matrix'') and Matrix Defined
Trusts.\1\
---------------------------------------------------------------------------

    \1\ 1 Applicants also request relief for existing and future
series (collectively, ``Series'') of Matrix Defined Trusts and of
other unit investment trusts sponsored by a Depositor (``Trusts'').
The ``Depositors'' are Matrix and any entity controlling, controlled
by or under common control with Matrix. Any future Trust and Series
that relies on the requested order will comply with the terms and
conditions of the application. All presently existing Trusts that
currently intend to rely on the requested order are named as
applicants.

Summary of Application: Applicants request an order to permit certain
unit investment trusts to: (a) Impose sales charges on a deferred basis
and waive the deferred sales charge in certain cases; (b) offer
unitholders certain exchange and rollover options; (c) publicly offer
units without requiring the Depositor to take for its own account or
place with others $100,000 worth of units; and (d) distribute capital
gains resulting from the sale of portfolio

---------------------------------------------------------------------------
securities within a reasonable time after receipt.

Filing Dates: The application was filed on January 15, 2008 and amended
on May 21, 2008.

Hearing or Notification of Hearing: An order granting the application
will be issued unless the Commission orders a hearing. Interested
persons may request a hearing by writing to the Commission's Secretary
and serving applicants with a copy of the request, personally or by
mail. Hearing requests should be received by the Commission by 5:30
p.m. on June 16, 2008, and should be accompanied by proof of service on
the applicants, in the form of an affidavit, or, for lawyers, a
certificate of service. Hearing requests should state the nature of the
writer's interest, the reason for the request, and the issues
contested. Persons who wish to be notified of a hearing may request
notification by writing to the Commission's Secretary.

ADDRESSES: Secretary, Securities and Exchange Commission, 100 F Street,
NE., Washington, DC 20549-1090; Applicants, 335 Madison Avenue, 11th
Floor, New York, NY 10017.

FOR FURTHER INFORMATION CONTACT: Laura L. Solomon, Senior Counsel, at
(202) 551-6915, or Julia Kim Gilmer, Branch Chief, at<PHONE_NUMBER>
(Office of Investment Company Regulation, Division of Investment
Management).

SUPPLEMENTARY INFORMATION: The following is a summary of the
application. The complete application may be obtained for a fee at the
Commission's Public Reference Desk, 100 F Street, NE., Washington, DC
20549-1520 (telephone<PHONE_NUMBER>).

Applicants' Representations

    1. Matrix Defined Trusts is a unit investment trust (``UIT'')
registered under the Act Any future Trust will be a UIT that will be
registered under the Act. Matrix, a New York corporation, is registered
under the Securities Exchange Act of 1934 as a broker-dealer and is the
depositor of Matrix Defined Trusts. Each Trust will be sponsored by a
Depositor. Each Series will be created by a trust indenture between the
Depositor and a banking institution or trust company as trustee
(``Trustee'').
    2. The Depositor acquires a portfolio of securities, which it
deposits with the Trustee in exchange for certificates representing
units of fractional undivided interest in the Series' portfolio
(``Units''). The Units are offered to the public through the Depositor
and dealers at a price which, during the initial offering period, is
based upon the aggregate market value of the underlying securities, or,
the aggregate offering side evaluation of the underlying securities if
the underlying securities are not listed on a securities exchange, plus
a front-end sales charge. The Depositor may reduce the sales charge in
compliance with rule 22d-1 under the Act in certain circumstances,
which are disclosed in the Series' prospectus.
    3. The Depositor currently intends, but is not legally obligated to
maintain a secondary market for Units of outstanding Series. Other
broker-dealers may or may not maintain a secondary market for Units of
a Series. If a secondary market is maintained, investors will be able
to purchase Units on the secondary market at the current public
offering price plus a front-end sales charge. If such a market is not
maintained at any time for any Series, holders of the Units
(``Unitholders'') of that Series may redeem their Units through the
Trustee.

A. Deferred Sales Charge and Waiver of Deferred Sales Charge under
Certain Circumstances

    1. Applicants request an order to the extent necessary to permit
one or more Series to impose a sales charge on a deferred basis
(``DSC''). For each Series, the Depositor would set a maximum sales
charge per Unit, a portion of which may be collected ``up front''
(i.e., at the time an investor purchases the Units). The DSC would be
collected subsequently in installments (``Installment Payments'') as
described in the application. The Depositor would not add any amount
for interest or any similar or related charge to adjust for such
deferral.
    2. When a Unitholder redeems or sells Units, the Depositor intends
to deduct any unpaid DSC from the redemption or sale proceeds. When
calculating the amount due, the Depositor will assume that Units on
which the DSC has been paid in full are redeemed or sold first. With
respect to Units on which the DSC has not been paid in full, the
Depositor will assume that the Units held for the longest time are
redeemed or sold first. Applicants represent that the DSC collected at
the time of redemption or sale, together with the Installment Payments
and any amount collected up front, will not exceed the maximum sales
charge per Unit. Under certain circumstances, the Depositor may waive
the collection of any unpaid DSC in connection with redemptions or
sales of Units. These circumstances will be disclosed in the prospectus
for the relevant Series and implemented in accordance with rule 22d-1
under the Act.
    3. Each Series offering Units subject to a DSC will state the
maximum charge per Unit in its prospectus. In addition, the prospectus
for such Series will include the table required by Form N-1A (modified
as appropriate to reflect the difference between UITs and open-end
management investment companies) and a schedule setting forth the
number and date of each Installment Payment, along with the duration of
the collection period. The prospectus also will disclose that portfolio
securities may be sold to pay an Installment Payment if distribution
income is insufficient and that securities will be sold pro rata or a
specific security will be designated for sale.

B. Exchange Option and Rollover Option

    1. Applicants request an order to the extent necessary to permit
Unitholders of a Series to exchange their Units for Units of another
Series (``Exchange Option'') and Unitholders of a Series that is
terminating to exchange their Units for Units of a new Series of the
same type (``Rollover Option''). The Exchange Option and Rollover
Option would apply to all exchanges of Units sold with a front-end
sales charge or DSC.
    2. A Unitholder who purchases Units under the Exchange Option or
Rollover Option would pay a lower sales charge than that which would be
paid for the Units by a new investor. The reduced sales charge will be
reasonably related to the expenses incurred in connection with the
administration of the DSC program, which may include an amount that
will fairly and adequately compensate the Depositor and participating
underwriters and brokers for their services in providing the DSC
program.
    3. Pursuant to the Exchange Option, an adjustment would be made if
Units of any Series are exchanged within five months of their
acquisition for Units of a Series with a higher sales charge (``Five
Months Adjustment''). An adjustment also would be made if Units on
which a DSC is collected are exchanged for Units of a Series that
imposes a front-end sales charge and the exchange occurs before the DSC
collected (plus any amount collected up front on the exchanged Units)
at least equals the per Unit sales charge on the acquired Units (``DSC
Front-End Exchange Adjustment''). If an exchange involves either the
Five Months Adjustment or the DSC Front-End Exchange Adjustment, the
Unitholder would pay the greater of the reduced sales charge or an
amount which, together with the sales charge already

paid on the exchanged Units, equals the normal sales charge on the
acquired Units on the date of the exchange. With appropriate
disclosures, the Depositor may waive such payment. Further, the
Depositor would reserve the right to vary the sales charge normally
applicable to a Series and the charge applicable to exchanges, as well
as to modify, suspend, or terminate the Exchange Option as set forth in
the conditions to the application.

Applicants' Legal Analysis

A. DSC and Waiver of DSC

    1. Section 4(2) of the Act defines a ``unit investment trust'' as
an investment company that issues only redeemable securities. Section
2(a)(32) of the Act defines a ``redeemable security'' as a security
that, upon its presentation to the issuer, entitles the holder to
receive approximately his or her proportionate share of the issuer's
current net assets or the cash equivalent of those assets. Rule 22c-1
under the Act requires that the price of a redeemable security issued
by a registered investment company for purposes of sale, redemption or
repurchase be based on the security's current net asset value
(``NAV''). Because the collection of any unpaid DSC may cause a
redeeming Unitholder to receive an amount less than the NAV of the
redeemed Units, applicants request relief from section 2(a)(32) and
rule 22c-1.
    2. Section 22(d) of the Act and rule 22d-1 under the Act require a
registered investment company and its principal underwriter and dealers
to sell securities only at the current public offering price described
in the investment company's prospectus, with the exception of sales of
redeemable securities at prices that reflect scheduled variations in
the sales load. Section 2(a)(35) of the Act defines the term ``sales
load'' as the difference between the sales price and the portion of the
proceeds invested by the depositor or trustee. Applicants request
relief from section 2(a)(35) and section 22(d) to permit waivers,
deferrals or other scheduled variations of the sales load.
    3. Under section 6(c) of the Act, the Commission may exempt classes
of transactions, if and to the extent that such exemption is necessary
or appropriate in the public interest and consistent with the
protection of investors and the purposes fairly intended by the policy
and provisions of the Act. Applicants state that their proposal meets
the standards of section 6(c). Applicants state that the provisions of
section 22(d) are intended to prevent (a) riskless trading in
investment company securities due to backward pricing, (b) disruption
of orderly distribution by dealers selling shares at a discount, and
(c) discrimination among investors resulting from different prices
charged to different investors. Applicants assert that the proposed DSC
program will present none of these abuses. Applicants further state
that all scheduled variations in the sales load will be disclosed in
the prospectus of each Series and applied uniformly to all investors,
and that applicants will comply with all the conditions set forth in
rule 22d-1.
    4. Section 26(a)(2)(C) of the Act, in relevant part, prohibits a
trustee or custodian of a UIT from collecting from the trust as an
expense any payment to the trust's depositor or principal underwriter.
Because the Trustee's payment of the DSC to the Depositor may be deemed
to be an expense under section 26(a)(2)(C), applicants request relief
under section 6(c) from section 26(a)(2)(C) to the extent necessary to
permit the Trustee to collect Installment Payments and disburse them to
the Depositor. Applicants submit that the relief is appropriate because
the DSC is more properly characterized as a sales load.

B. Exchange Option and Rollover Option

    1. Sections 11(a) and 11(c) of the Act prohibit any offer of
exchange by a UIT for the securities of another investment company
unless the terms of the offer have been approved in advance by the
Commission. Applicants request an order under sections 11(a) and 11(c)
for Commission approval of the Exchange Option and the Rollover Option.
Applicants state that the Five Months Adjustment and the DSC Front-End
Exchange Adjustment in certain circumstances are appropriate to
maintain the equitable treatment of various investors in each Series.

C. Net Worth Requirement

    1. Section 14(a) of the Act requires that a registered investment
company have $100,000 of net worth prior to making a public offering.
Applicants state that each Series will comply with this requirement
because the Depositor will deposit more than $100,000 of securities.
Applicants assert, however, that the Commission has interpreted section
14(a) as requiring that the initial capital investment in an investment
company be made without any intention to dispose of the investment.
Applicants state that, under this interpretation, a Series would not
satisfy section 14(a) because of the Depositor's intention to sell all
the Units of the Series.
    2. Rule 14a-3 under the Act exempts UITs from section 14(a) if
certain conditions are met, one of which is that the UIT invest only in
``eligible trust securities,'' as defined in the rule. Applicants state
that they may not rely on rule 14a-3 because certain Series
(collectively, ``Equity Series'') will invest all or a portion of their
assets in equity securities or shares of registered investment
companies which do not satisfy the definition of eligible trust
securities.
    3. Applicants request an exemption under section 6(c) of the Act to
the extent necessary to exempt the Equity Series from the net worth
requirement in section 14(a). Applicants state that the Series and the
Depositor will comply in all respects with the requirements of rule
14a-3, except that the Equity Series will not restrict their portfolio
investments to ``eligible trust securities.''

D. Capital Gains Distribution

    1. Section 19(b) of the Act and rule 19b-1 under the Act provide
that, except under limited circumstances, no registered investment
company may distribute long-term gains more than once every twelve
months. Rule 19b-1(c), under certain circumstances, exempts a UIT
investing in eligible trust securities (as defined in rule 14a-3) from
the requirements of rule 19b-1. Because the Equity Series do not limit
their investments to eligible trust securities, however, the Equity
Series will not qualify for the exemption in paragraph (c) of rule 19b-
1. Applicants therefore request an exemption under section 6(c) from
section 19(b) and rule 19b-1 to the extent necessary to permit capital
gains earned in connection with the sale of portfolio securities to be
distributed to Unitholders along with the Equity Series' regular
distributions. In all other respects, applicants will comply with
section 19(b) and rule 19b-1.
    2. Applicants state that their proposal meets the standards of
section 6(c). Applicants assert that any sale of portfolio securities
would be triggered by the need to meet Trust expenses, Installment
Payments, or by redemption requests, events over which the Depositor
and the Equity Series do not have control. Applicants further state
that, because principal distributions must be clearly indicated in
accompanying reports to Unitholders as a return of principal and will
be relatively small in comparison to normal dividend distributions,
there is

little danger of confusion from failure to differentiate among
distributions.

Applicants' Conditions

    Applicants agree that any order granting the requested relief will
be subject to the following conditions:

A. DSC Relief and Exchange and Rollover Options

    1. Whenever the Exchange Option or the Rollover Option is to be
terminated or its terms are to be amended materially, any holder of a
security subject to that privilege will be given prominent notice of
the impending termination or amendment at least 60 days prior to the
date of termination or the effective date of the amendment, provided
that: (a) no such notice need be given if the only material effect of
an amendment is to reduce or eliminate the sales charge payable at the
time of an exchange, to add one or more new Series eligible for the
Exchange Option or the Rollover Option, or to delete a Series which has
terminated; and (b) no notice need be given if, under extraordinary
circumstances, either (i) there is a suspension of the redemption of
Units of the Series under section 22(e) of the Act and the rules and
regulations promulgated thereunder, or (ii) a Series temporarily delays
or ceases the sale of its Units because it is unable to invest amounts
effectively in accordance with applicable investment objectives,
policies and restrictions.
    2. An investor who purchases Units under the Exchange Option or the
Rollover Option will pay a lower sales charge than that which would be
paid for the Units by a new investor.
    3. The prospectus of each Series offering exchanges or rollovers
and any sales literature or advertising that mentions the existence of
the Exchange Option or Rollover Option will disclose that the Exchange
Option and the Rollover Option are subject to modification, termination
or suspension without notice, except in certain limited cases.
    4. Any DSC imposed on a Series' Units will comply with the
requirements of subparagraphs (1), (2) and (3) of rule 6c-10(a) under
the Act.
    5. Each Series offering Units subject to a DSC will include in its
prospectus the disclosure required by Form N-1A relating to deferred
sales charges (modified as appropriate to reflect the differences
between UITs and open-end management investment companies) and a
schedule setting forth the number and date of each Installment Payment.

B. Net Worth Requirement

    1. Applicants will comply in all respects with the requirements of
rule 14a-3, except that the Equity Series will not restrict their
portfolio investments to ``eligible trust securities.''

    For the Commission, by the Division of Investment Management,
under delegated authority.
Nancy M. Morris,
Secretary.
[FR Doc. E8-11943 Filed 5-28-08; 8:45 am]

BILLING CODE 8010-01-P


Pyrasulfotole (000692)

Screening Level Usage Analysis (SLUA)

Date: January 29, 2016

What is a Screening Level Usage Analysis (SLUA)?

Available estimates of pesticide usage data for a particular active
ingredient that is used on agricultural crops in the United States.

Pesticide usage data obtained from various sources.  The data are then
merged, averaged, and rounded so that the presented information is not
proprietary, business confidential, or trade secret.

What does it contain?

Pesticide usage data for a single active ingredient only.

Agricultural use sites (crops) that the pesticide is reported to be used
on.

Available pesticide usage information from states that produce 80% of
crop acres planted in the United States, in most cases, or less than
80%, in rare cases, depending on the scope of the survey and available
resources.

Annual percent of crop treated (average & maximum) for each agricultural
crop.

Average annual pounds of the pesticide applied for each agricultural
crop (i.e., for the states surveyed, not for the entire United States).

What assumptions can I make about the reported data?

Average pounds of active ingredient applied - Values are calculated by
merging pesticide usage data sources together; averaging across all
observations, then rounding.  Note:  If the estimated value is less than
500, then that value is labeled <500.  Estimated values between 500 &
<1,000,000 are rounded to 1 significant digit.  Estimated values of
1,000,000 or greater are rounded to 2 significant digits.)

Average percent of crop treated - Values are calculated by merging data
sources together; averaging by year, averaging across all years, &
rounding to the nearest multiple of 5.  Note:  If the estimated value is
less than 2.5, then the value is labeled <2.5.  If the estimated value
is less than 1, then the value is labeled <1.

Maximum percent of crop treated - Value is the single maximum value
reported across all data sources, across all years, & rounded up to the
nearest multiple of 5.  Note:  If the estimated value is less than 2.5,
then the value is labeled <2.5.

What are the data sources used?

United States Department of Agriculture’s National Agricultural
Statistics Service (USDA-NASS) – pesticide usage data from 2005 to
2014.  NASS data are based on surveys that focus on the top-producing
states that together account for the majority of U.S. acres or
production of the surveyed commodity.  NASS aims to cover at a minimum
80 percent of the targeted fruit, vegetable, and field crop acres
planted in the United States. Farm level data are combined during
summary and, pending compliance with disclosure rules, published at the
state and national levels.  NASS collects agricultural usage data for
various crops on a rotating schedule.

Private pesticide market research – pesticide usage data from 2005 to
2013.  The Private Pesticide Market Research data is also a survey that
covers pesticide usage on agricultural crops.  The survey data accounts
for at least 80 percent of US acres/production of the surveyed
commodities.  Surveys are conducted annually.

California Department of Pesticide Regulation (DPR) Pesticide Use
Reporting (PUR) data for 2005 to 2012. The PUR database contains
detailed records and summaries of agricultural applications of
pesticides on crops that are obtained from a census and published
annually.

What are the limitations to the data?

Additional registered uses may exist but are not included because the
available surveys do not report usage (e.g., small acreage crops).

Lack of reported usage data for the pesticide on a crop does not imply
zero usage.

Usage data on a particular site may be noted in data sources, but not
quantified.  In these instances, the site would not be reported in the
SLUA.

Non-agricultural use sites (e.g., turf, post-harvest, mosquito control,
etc.) are not reported in the SLUA.  A separate request must be made to
receive these estimates.

Some sites show some use, even though they are not on the label.  This
usage could be due to various factors, including, but not limited to
Section 18 requests, existing stocks of the chemical, data collection
errors, and experimental use permits (EUPs).

Date: January 29, 2016

Screening Level Estimates of Agricultural Uses of Pyrasulfotole (000692)

Sorted Alphabetically – Reporting Time:  2005-2014

Percent Crop Treated

Crop	Annual

Average Lbs. A.I.

Applied per Year	Annual

Average	Maximum

1	Barley	9,000	10	15

2	Sorghum+	10,000	5	10

3	Wheat	90,000	5	15

	All numbers are rounded.

  +:  Sorghum is not known to be listed on active end use product
registrations or as Section 18 emergency

       exemptions when this report was run.

SLUA data sources include:

USDA-NASS (United States Department of Agriculture's National
Agricultural Statistics Service)

Private Pesticide Market Research

These results reflect amalgamated data developed by the Agency and are
releasable to the public.